Year 2024 / Volume 116 / Number 6
Special Article
Strategic analysis and recommendations of the Sociedad Española de Patología Digestiva (SEPD) regarding population-based screening programs for colorectal cancer in Spain

319-329

DOI: 10.17235/reed.2024.10458/2024

Agustín Albillos, Fernando Carballo, Javier Crespo, Fernando Alberca on behalf of Grupo de investigadores colaboradores del proyecto «Libro Blanco del Cribado Poblacional de Cáncer Colorrectal en España» de la Sociedad Española de Patología Digestiva (SEPD)*,

* Grupo de investigadores colaboradores del proyecto «Libro Blanco del Cribado Poblacional de Cáncer Colorrectal en España» de la Sociedad Española de Patología Digestiva (SEPD): Fernando Alberca, Sergio Alonso, Javier Amador, Elena Bartolomé, Antonio Buño, Ángel Caunedo, Mar Iglesias, José Díaz Tasende, Blas Flor-Lorente, Noelia Fontanillas, Luis M. De la Fuente, Tamara García, Javier Granda, Jaume Grau, Manuel Hernández- Guerra , Ángel Lanas, Federico Longo, José Martínez, Pedro Pérez, Laura M. Quintás, Eduardo Redondo, Francisco Robles, Adolfo Suárez, Carlos I. Tourné, Juan Turnes, Vicenzo Vigorita, Antonio Zapatero

Abstract
Introduction: population-based screening programs are effective to reduce colorectal cancer-related mortality and incidence. However, given their complex development, sound organization and design do not warrant success. This study provides a strategic analysis of the Spanish programs, as well as recommendations in an attempt to contribute to their optimization. Methods: a multidisciplinary panel of researchers, supported by the Sociedad Española de Patología Digestiva (SEPD), has performed a SWOT (strengths, weaknesses, opportunities and threats) analysis, from which a proposal of recommendations was developed; their adequacy was judged using an adapted version of the RAND/UCLA method. Results: 5 weaknesses, 3 threats, 5 strengths and 5 opportunities were identified, and a total of 15 recommendations were developed emphasizing aspects with room for improvement in program orientation, particularly the need to increase participation, fight variability and inequities, improve information processes and systems quality, ensure specific, adequate funding, and evaluate health results. Conclusion: promoting an operational collaboration framework between all the public health and care levels involved should facilitate effective communication with society regarding the benefits of taking part in population screening programs while persuading decision and policy makers of the critical importance of taking an active, determined stance regarding its implementation.
Share Button
New comment
Comments
No comments for this article
References
Bibliografía
1. Las cifras del cáncer en España 2024: Sociedad Española de Oncología Médica; 2024 [consultado 05 Feb 2024]. Disponible en: https://seom.org/images/publicaciones/informes-seom-de-evaluacion-de-farmacos/LAS_CIFRAS_2024.pdf.
2. Estimaciones de la incidencia del cáncer en España, 2024 [pdf]: Red Española de Registros de Cáncer (REDECAN); 2024 [consultado 11 Feb 2024]. Disponible en: https://redecan.org/storage/documents/031b5800-a7fe-4c2b-8a09-a38d046365df.pdf.
3. Global Cancer Observatory [Internet]. The International Agency for Research on Cancer; 2024 [consultado 11 Feb 2024]. Disponible en: https://gco.iarc.fr/.
4. European Cancer Information System [Internet]. European Cancer Information System (ECIS; 2024 [consultado 13 Feb 2024]. Disponible en: https://ecis.jrc.ec.europa.eu/.
5. Hewitson P, Glasziou P, Irwig L, Towler B, Watson E. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev. 2007(1):CD001216. Epub 2007/01/27. doi: 10.1002/14651858.CD001216.pub2. PubMed PMID: 17253456.
6. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343(22):1603-7. doi: 10.1056/nejm200011303432203. PubMed PMID: 11096167.
7. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993;329(27):1977-81. doi: 10.1056/NEJM199312303292701. PubMed PMID: 8247072.
8. Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116(3):544-73. Epub 2009/12/10. doi: 10.1002/cncr.24760. PubMed PMID: 19998273.
9. Cardoso R, Guo F, Heisser T, Hackl M, Ihle P, De Schutter H, et al. Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study. Lancet Oncol. 2021;22(7):1002-13. Epub 20210525. doi: 10.1016/s1470-2045(21)00199-6. PubMed PMID: 34048685.
10. Sharma R, Abbasi-Kangevari M, Abd-Rabu R, Abidi H, Abu-Gharbieh E, Acuna JM, et al. Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet Gastroenterology & Hepatology. 2022;7(7):627-47. doi: 10.1016/s2468-1253(22)00044-9.
11. Shaukat A, Levin TR. Current and future colorectal cancer screening strategies. Nature Reviews Gastroenterology & Hepatology. 2022;19(8):521-31. doi: 10.1038/s41575-022-00612-y.
12. Senore C, Lansdorp-Vogelaar I, de Jonge L, Rabeneck L. Rationale for organized Colorectal cancer screening programs. Best Practice & Research Clinical Gastroenterology. 2023;66:101850. doi: https://doi.org/10.1016/j.bpg.2023.101850.
13. Ascunce N, Salas D, Zubizarreta R, Almazán R, Ibáñez J, Ederra M. Cancer screening in Spain. Ann Oncol. 2010;21 Suppl 3:iii43-51. doi: 10.1093/annonc/mdq085. PubMed PMID: 20427360.
14. Orden SSI/2065/2014, de 31 de octubre, por la que se modifican los anexos I, II y III del Real Decreto 1030/2006, de 15 de septiembre, por el que se establece la cartera de servicios del Sistema Nacional de Salud y el procedimiento para su actualización. Boletín Oficial del Estado, 269, de 6 de noviembre de 2014. https://www.boe.es/eli/es/o/2014/10/31/ssi20.
15. Estrategia en Cáncer del Sistema Nacional de Salud. Actualización aprobada por el Consejo Interterritorial del Sistema Nacional de Salud, el 22 de octubre de 2009 [pdf]. Madrid: Ministerio de Sanidad y Política Social; 2010 [consultado 09 Ene 2024]. Disponible en: https://www.sanidad.gob.es/areas/calidadAsistencial/estrategias/cancer/docs/ActualizacionEstrategiaCancer.pdf.
16. Estrategia en Cáncer del Sistema Nacional de Salud. Actualización aprobada por el Consejo Interterritorial del Sistema Nacional de Salud, el 24 de febrero de 2021 [pdf]. Madrid: Ministerio de Sanidad; 2021 [consultado 09 Ene 2024]. Disponible en: https://www.sanidad.gob.es/areas/calidadAsistencial/estrategias/cancer/docs/ESTRATEGIA_EN_CANCER_DEL_SNS.pdf.
17. Red de Programas de Cribado de Cáncer [Internet]. Red de Programas de Cribado de Cáncer; 2024 [consultado 09 Ene 2024]. Disponible en: https://cribadocancer.es/.
18. Ministerio de Sanidad - Profesionales - Ponencia de cribado poblacional [Internet]. Ministerio de Sanidad; 2024 [consultado 09 Ene 2024]. Disponible en: https://www.sanidad.gob.es/areas/promocionPrevencion/cribado/ponenciaPoblacional.htm.
19. Parra-Blanco A, Gimeno-García AZ, Quintero E, Nicolás D, Moreno SG, Jiménez A, et al. Diagnostic accuracy of immunochemical versus guaiac faecal occult blood tests for colorectal cancer screening. J Gastroenterol. 2010;45(7):703-12. Epub 20100217. doi: 10.1007/s00535-010-0214-8. PubMed PMID: 20157748.
20. Van Rossum LG, Van Rijn AF, Laheij RJ, Van Oijen MG, Fockens P, Van Krieken HH, et al. Random Comparison of Guaiac and Immunochemical Fecal Occult Blood Tests for Colorectal Cancer in a Screening Population. Gastroenterology. 2008;135(1):82-90. doi: 10.1053/j.gastro.2008.03.040.
21. Wieten E, Schreuders EH, Grobbee EJ, Nieboer D, Bramer WM, Lansdorp-Vogelaar I, et al. Incidence of faecal occult blood test interval cancers in population-based colorectal cancer screening: a systematic review and meta-analysis. Gut. 2019;68(5):873-81. doi: 10.1136/gutjnl-2017-315340.
22. Albillos A, Carballo F, Crespo J. Situación actual del cribado poblacional de cáncer colorrectal en España. Madrid: Sociedad Española de Patología Digestiva; 2024 [consultado 14 Mar 2024]. Disponible en: https://www.sepd.es/observatorio-cancer-colonsituacioncribado.
23. Fitch K, Bernstein SJ, Aguilar MD, Burnand B, LaCalle JR, Lazaro P, et al. RAND/UCLA Appropriateness Method User's Manual [pdf]. Santa Monica, CA: RAND Corporation; 2001 [consultado 09 Ene 2024]. Disponible en: https://www.rand.org/content/dam/rand/pubs/monograph_reports/2011/MR1269.pdf.
24. Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O'Neal L, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;95:103208. Epub 20190509. doi: 10.1016/j.jbi.2019.103208. PubMed PMID: 31078660; PubMed Central PMCID: PMC7254481.
25. Morillas JD, Castells A, Oriol I, Pastor A, Pérez-Segura P, Echevarría JM, et al. Alianza para la Prevención del Cáncer de Colon en España: un compromiso cívico con la sociedad. Gastroenterol Hepatol. 2012;35(3):109-28. Epub 20120223. doi: 10.1016/j.gastrohep.2012.01.002. PubMed PMID: 22365571.
26. Sanidad ampliará el cribado colorrectal hasta los 74 años [Internet]. Madrid: Ministerio de Sanidad; 2024 [consultado 23 Mar 2024]. Disponible en: https://www.sanidad.gob.es/en/gabinete/notasPrensa.do?id=6382.
27. Unión Europea. Recomendación del Consejo de 9 de diciembre de 2022 relativa a la mejora de la prevención mediante la detección precoz: un nuevo enfoque de la UE para el cribado del cáncer en sustitución de la Recomendación 2003/878/CE (2022/C 473/01). https://eur-lex.europa.eu/legal-content/CS/TXT/PDF/?uri=CELEX:32022H1213(01).
28. Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram-Baptiste D, Saslow D, Wender RC. Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2019;69(3):184-210. Epub 20190315. doi: 10.3322/caac.21557. PubMed PMID: 30875085.
29. Red de programas de Cribado de Cáncer. Evaluación programas de cribado de cáncer colorrectal 2019. [pdf]: Red de Programas de Cribado de Cáncer; 2023 [consultado 09 Ene 2024]. Disponible en: https://cribadocancer.es/indicadores-cancer-colorrectal/.
30. European Commission, Directorate-General for Health and Consumers, Executive Agency for Health and Consumers, World Health Organization, Karsa L, Patnick J, Segnan N. European guidelines for quality assurance in colorectal cancer screening and diagnosis [pdf]: Publications Office; 2010 [consultado 09 Ene 2024]. Disponible en: https://data.europa.eu/doi/10.2772/1458.
31. Molina-Barceló A, Moreno Salas J, Peiró-Pérez R, Arroyo G, Ibáñez Cabanell J, Vanaclocha Espí M, et al. Desigualdades de acceso a los programas de cribado del cáncer en España y cómo reducirlas: datos de 2013 y 2020. Rev Esp Salud Publica. 2021;95. Epub 20210126. PubMed PMID: 33496270.
32. Binefa G, García M, Peiró R, Molina-Barceló A, Ibáñez R. Cómo evaluar y reducir desigualdades sociales en los programas de cribado de cáncer. Gac Sanit. 2016;30(3):232-4. Epub 20160223. doi: 10.1016/j.gaceta.2016.01.008. PubMed PMID: 26920750.
33. López Salas M, de Haro Gázquez D, Fernández Sánchez B, Amador Muñoz ML. Knowledge, Compliance, and Inequities in Colon Cancer Screening in Spain: An Exploratory Study. Healthcare (Basel). 2023;11(18). Epub 20230906. doi: 10.3390/healthcare11182475. PubMed PMID: 37761672; PubMed Central PMCID: PMC10530971.
34. Fernández Sánchez B, Diego de Haro Gazquez D, López Salas M, Amador Muñoz ML, Blanco Álvarez M, Fernández Marcos A, et al. Estudio sobre los programas de cribado de cáncer colorrectal. Conocimiento, actitudes y comportamientos de las personas de 50 a 69 años [pdf]. Madrid: Asociación Española contra el Cáncer; 2022 [consultado 09 Ene 2024]. Disponible en: https://observatorio.contraelcancer.es/informes/estudio-sobre-los-programas-de-cribado-de-cancer-colorrectal.
Related articles

Digestive Diseases Image

Spontaneous regression of a rectal cancer

DOI: 10.17235/reed.2023.9486/2023

Letter

Vaginal lesion as first manifestation of colorectal disease

DOI: 10.17235/reed.2022.9270/2022

Review

Inflammatory bowel disease and solid organ transplantation

DOI: 10.17235/reed.2020.7361/2020

Review

New non-invasive biomarkers for colorectal cancer screening

DOI: 10.17235/reed.2020.7233/2020

Letter

Medullary colorectal carcinoma. Do we really know it?

DOI: 10.17235/reed.2020.6728/2019

Letter

The rectosigmoid junction: are limits important?

DOI: 10.17235/reed.2019.5983/2018

Editorial

Colorectal cancer screening and survival

DOI: 10.17235/reed.2018.5870/2018

Letter to the Editor

Liver metastasis from colorectal cancer 12 years after liver transplantation

DOI: 10.17235/reed.2017.4507/2016

Review

Serrated lesions and serrated polyposis syndrome

DOI: 10.17235/reed.2017.4065/2015

Letter to the Editor

Endobronchial metastases of colorectal cancer

DOI: 10.17235/reed.2016.4080/2015

Citation tools
Albillos A, Carballo F, Crespo J, Alberca F. Strategic analysis and recommendations of the Sociedad Española de Patología Digestiva (SEPD) regarding population-based screening programs for colorectal cancer in Spain. 10458/2024


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 1584 visits.
This article has been downloaded 281 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 05/04/2024

Accepted: 09/04/2024

Online First: 20/05/2024

Published: 04/06/2024

Article Online First time: 45 days

Article editing time: 60 days


Share
This article hasn't been rated yet.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology